Research study suggests that neurological symptoms observed in COVID-19 clients could indicate an increased risk of neurodegeneration, possibly resulting in conditions like Alzheimers illness (AD).
Neurological symptoms in COVID-19 patients might show an increased risk for Alzheimers disease, with age being a significant element for both conditions. Current research study is exploring this prospective connection in information.
The numerous neurological symptoms that patients with COVID-19 have actually experienced recommend that viral infections may increase the threat of neurodegeneration, which could in turn contribute to the advancement of conditions such as Alzheimers disease (AD). A review in the Journal of Neurochemistry highlights the potential mechanistic links in between COVID-19 and AD.
The authors note that age is the largest contributing aspect to AD and COVID-19, and both appear to improve the results of the other, with potentially synergistic impacts on neurodegeneration.
By Wiley
October 22, 2023
” I think over the next several years, emerging proof will even more support a link in between microbial infection and neurodegenerative illness,” stated corresponding author Thomas E. Lane, PhD, of the University of California, Irvine. “With regards to advertisement, our lab is now infecting various pressures of transgenic AD mice with both murine (mouse) coronaviruses along with murine-adapted SARS-CoV-2 to evaluate impacts on AD neuropathology. Were delighted to see how coronavirus infection affects illness severity.”
Referral: “COVID-19 and the effect on Alzheimers illness pathology” by Susana Furman, Kim Green and Thomas E. Lane, 18 October 2023, Journal of Neurochemistry.DOI: 10.1111/ jnc.15985.
